We would like to thank members for their very detailed submissions to date which has allowed us to develop a robust response which strongly challenges the proposed fees increase.
Head of Programmes and Policy, Paul Fisher says “We work closely with the MHRA and value our relationship with them. However, above all we have a duty to support members and the IVD industry. The MHRA fees proposal to charge by GMDN codes will see member fees rising by an average of 5,550%. The plans are flawed and I know have caused members a great deal of concern.
We have been in regular dialogue with the MHRA, including submitting an FOI request for their financial modelling. Our consultation response is a detailed rebuttal of their proposals. I’m optimistic that the MHRA will listen to reason and a more equitable model will follow.”
BIVDA’s regulatory manager, Neil Plumridge would like to personally thank members. “Since we received the MHRA proposal, our members have submitted a large volume of evidence and financial modelling – no doubt a sign of the concern these proposals generated. This has made our response much more robust, and I’m genuinely grateful to all those who have supported this submission.
